Last10K.com

Dentsply Sirona Inc. (XRAY) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2018

Dentsply Sirona Inc.

CIK: 818479 Ticker: XRAY

xraya07.jpg
Dentsply Sirona Reports Preliminary Fourth Quarter and Full Year 2018 Results


Reported Q4 revenues of $1,059.7 million, down 2.9%, and down 0.1% on an internal sales growth basis. [1]
Q4 2018 US GAAP EPS of $0.01 vs. a loss of $2.85 in Q4 2017. Q4 2018 Non-US GAAP EPS of $0.58 compared with Non-US GAAP EPS of $0.82 in Q4 2017.
4Q18 Cash Flow from Operations of $202.1 million, less Capital Expenditures of $51.9 million resulted in 4Q18 Free Cash Flow of $150.2 million.
The Company issued 2019 guidance and anticipates 2019 Non-US GAAP adjusted EPS in the range of $2.25 to $2.40.


York, Pennsylvania, March 1, 2019
- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), The Dental Solutions Company, today announced its preliminary financial results for the three and twelve months ended December 31, 2018.

Preliminary Fourth Quarter 2018 Financial Results

Reported net sales of $1,059.7 million declined 2.9% compared to $1,091.0 million in the fourth quarter of 2017, and declined 0.1% on an internal sales growth basis. Revenues saw solid increases in Europe, up 4.6% (+8.7% on an internal sales growth basis), and in the Rest of World, up 1.4% (+7.1% on an internal sales growth basis). This was partially offset by declines in the U.S., down 14.7% (-16.3% on an internal sales growth basis), driven by expected high levels of dealer destocking during the quarter. 

Net income attributable to Dentsply Sirona for the fourth quarter of 2018 was $1.8 million, or $0.01 per diluted share, compared to a net loss of $650.4 million, or $2.85 per diluted share, in the fourth quarter of 2017. On an adjusted basis, excluding certain items, non-US GAAP net earnings per diluted share were $0.58 compared to $0.82 in the fourth quarter of 2017. A reconciliation of the non-US GAAP measures to earnings per share calculated on a US GAAP basis is provided in the attached tables.

Fourth quarter Consumable revenues increased by 3.4% and increased by 5.4% on an internal sales growth basis. Consumable segment revenue growth benefited from a recovery in shipment levels at our European distribution center in Venlo, the Netherlands.

Technology & Equipment revenues declined by 7.4% in the fourth quarter of 2018, down 4.1% on an internal sales growth basis. Fourth quarter Technology & Equipment revenues were impacted by $31 million of inventory destocking, as compared to inventory stocking of $21 million in the fourth quarter of 2017. Excluding inventory stocking and destocking in both quarters, Technology & Equipment fourth quarter internal revenues would have increased as compared to the fourth quarter of the prior year.

Don Casey, Chief Executive Officer of Dentsply Sirona, commented: “Although fiscal 2018 financial results were disappointing, we have taken important steps to position the company for improved
xraylineonly.jpg
1

The following information was filed by Dentsply Sirona Inc. (XRAY) on Friday, March 1, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Dentsply Sirona Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Dentsply Sirona Inc..

Continue

Assess how Dentsply Sirona Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Dentsply Sirona Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Revenue
Financial
M & A
Other
Filter Subcategory:
All
Product
Expense
Income
Cash Flow
Shares
Earnings
Dividend
Geography
Debt
Other
Inside Dentsply Sirona Inc.'s 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Informaiton
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Equity
Consolidated Statements Of Changes In Equity (Parenthetical)
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Operations
Accrued Liabilities
Accrued Liabilities (Details)
Accrued Liabilities (Tables)
Benefit Plans
Benefit Plans (Tables)
Benefit Plans - Additional Information (Details)
Benefit Plans - Amounts Recognized In Accumulated Other Comprehensive Income (Details)
Benefit Plans - Componenets Of Net Periodic Benefit Cost (Details)
Benefit Plans - Estimated Future Benefit Payments On Defined Benefit Plan (Details)
Benefit Plans - Fair Value Of Pension Plan Assets (Details)
Benefit Plans - Other Changes In Plan Assets And Benefit Obligations Recognized In Aoci (Details)
Benefit Plans - Pension Benefits And Other Postretirement Benefits Recognized In The Accompanying Consolidated Balance Sheets (Details)
Benefit Plans - Pension Plans With An Accumulated Benefit Obligation In Excess Of Plan Assets (Details)
Benefit Plans - Reconciliation For The Plan Assets Categorized As Level 3 (Details)
Benefit Plans - Reconciliation Of Changes In The Defined Benefit And Postretirement Healthcare Plans' Benefit Obligations, Fiar Value Of Assets And Funded Status (Details)
Benefit Plans - The Amounts In Aoci That Are Expected To Be Amortized As Net Expense (Income) During Next Fiscal Year (Details)
Benefit Plans - Weighted Average Assumptions Used To Determine Benefit Obligations (Details)
Benefit Plans - Weighted Average Assumptions Used To Determine Net Periodic Benefit Cost Trend Rates (Details)
Business Combinations
Business Combinations (Tables)
Business Combinations - Additional Information (Details)
Business Combinations - Pro Forma Information (Details)
Business Combinations - Summary Of Consideration (Details)
Business Combinations - Summary Of Intangible Assets (Details)
Commitments And Contingencies
Commitments And Contingencies (Tables)
Commitments And Contingencies - Additional Information (Details)
Commitments And Contingencies - Rental Commitments (Details)
Comprehensive Income
Comprehensive Income (Tables)
Comprehensive Income - Additional Information (Details)
Comprehensive Income - Changes In Aoci (Details)
Comprehensive Income - Reclassification Out Of Accumulated Other Comprehensive Income (Expense) (Details)
Earnings Per Common Share
Earnings Per Common Share (Tables)
Earnings Per Common Share - Additional Information (Details)
Earnings Per Common Share - Computation Of Basic And Diluted Earnings Per Common Share (Details)
Equity
Equity (Tables)
Equity - Additional Information (Details)
Equity - Assumptions Used To Determine Compensation Cost For The Company's Non-Qualified Stock Options Issued (Details)
Equity - Information About Non-Qualified Stock Options Outstanding (Details)
Equity - Non-Qualified Stock Option Transactions (Details)
Equity - Total Outstanding Shares (Details)
Equity - Total Stock Based Compensation Expense And The Tax Related Benefit (Details)
Equity - Unvested Rsu Transactions (Details)
Fair Value Measurement
Fair Value Measurement (Tables)
Fair Value Measurement - Additional Information (Details)
Fair Value Measurement - Financial Assets And Liabilities That Are Recorded At Fair Value And Classified Based On The Lowest Level Of Input (Details)
Financial Instruments And Derivatives
Financial Instruments And Derivatives (Tables)
Financial Instruments And Derivatives - Additional Information (Details)
Financial Instruments And Derivatives - Balance Sheet Allocation (Details)
Financial Instruments And Derivatives - Balance Sheet Offsetting (Details)
Financial Instruments And Derivatives - Cash Flow Hedges (Details)
Financial Instruments And Derivatives - Gain (Loss) Recorded In Aoci Cash Flow Hedges (Details)
Financial Instruments And Derivatives - Gain (Loss) Recorded In Aoci For Hedges Not Designated (Details)
Financial Instruments And Derivatives - Gain (Loss) Recorded In Aoci Net Investment Hedges (Details)
Financial Instruments And Derivatives - Hedges Not Designated (Details)
Financial Instruments And Derivatives - Net Investment Hedges (Details)
Financing Arrangements
Financing Arrangements (Tables)
Financing Arrangements - Additional Information (Details)
Financing Arrangements - Contractual Maturity Dates Of The Vairous Borrowings (Details)
Financing Arrangements - Long Term Borrowings (Details)
Financing Arrangements - Short Term Borrowings (Details)
Goodwill And Intangible Assets
Goodwill And Intangible Assets (Tables)
Goodwill And Intangible Assets - Additional Information (Details)
Goodwill And Intangible Assets - Goodwill By Reportable Segment (Details)
Goodwill And Intangible Assets - Goodwill Carrying Amount (Details)
Goodwill And Intangible Assets - Identifiable Definite-Lived Assets (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Components Of Income Before Income Taxes From Operations (Details)
Income Taxes - Components Of The Provision For Income Taxes From Operations (Details)
Income Taxes - The Deferred Tax Assets And Liabilities (Details)
Income Taxes - The Reconciliation Of The U.S. Federal Statutory Tax Rate To The Effective Rate (Details)
Income Taxes - The Tax Effect Of Significant Temporary Differences Giving Rise To Deferred Tax Assets And Liabilities (Details)
Income Taxes - Unrecognized Tax Benefits (Details)
Inventories, Net
Inventories, Net (Details)
Inventories, Net (Tables)
Inventories, Net - Additional Information (Details)
Other Expense (Income) , Net (Details)
Other Expense (Income) , Net (Tables)
Other Expense (Income), Net
Prepaid Expenses And Other Current Assets
Prepaid Expenses And Other Current Assets (Details)
Prepaid Expenses And Other Current Assets (Tables)
Property, Plant And Equipment, Net
Property, Plant And Equipment, Net (Details)
Property, Plant And Equipment, Net (Tables)
Quarterly Financial Information (Unaudited)
Quarterly Financial Information (Unaudited) (Details)
Quarterly Financial Information (Unaudited) (Tables)
Restructuring And Other Costs
Restructuring And Other Costs (Tables)
Restructuring And Other Costs - Additional Information (Details)
Restructuring And Other Costs - Provisions And Adjustments And Amounts Applied For All Plans By Segment (Details)
Restructuring And Other Costs - Restructuring Accruals (Details)
Schedule Ii - Valuation And Qualifying Accounts
Schedule Ii - Valuation And Qualifying Accounts (Details)
Segment And Geographic Information
Segment And Geographic Information (Tables)
Segment And Geographic Information - Assets (Details)
Segment And Geographic Information - Capital Expenditures (Details)
Segment And Geographic Information - Concentration Risk (Details)
Segment And Geographic Information - Depreciation And Amortization (Details)
Segment And Geographic Information - Information About The Company's Operatings In Different Geographic Areas (Details)
Segment And Geographic Information - Net Sales (Details)
Segment And Geographic Information - Net Sales, Excluding Precious Metal Content (Details)
Segment And Geographic Information - Schedule Of Sales By Product Category (Details)
Segment And Geographic Information - Segment Operating Income (Loss) (Details)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Significant Accounting Policies - Additional Information (Details)
Significant Accounting Policies - Description Of Business (Details)
Significant Accounting Policies - Restatement Adjustments (Details)
Significant Accounting Policies - Schedule Of Intangible Assets (Details)
Significant Accounting Policies - Schedule Of Warranties (Details)
Ticker: XRAY
CIK: 818479
Form Type: 10-K Annual Report
Accession Number: 0000818479-19-000010
Submitted to the SEC: Fri Mar 08 2019 3:33:04 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Monday, December 31, 2018
Industry: Dental Equipment And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/xray/0000818479-19-000010.htm